Co-founders Brady Fish (MBA) and Stefano Olgiati (DSc, FRSM, PhD, MSc(Hons), ACE(MIT)) met at the Harvard Medical School in Boston in 2016.
The idea behind SPEKTRAL was conceived while preparing for an exam on the well-known case of Betsy A. Lehman, a Boston Globe columnist aged 39 in 1995 who died receiving massive overdoses of an experimental treatment for advanced breast cancer at one of the country's most prestigious cancer hospitals. Doctors apparently refused to heed her warnings that something was drastically wrong. After the event, officials at the hospital were at a loss to explain how such a serious medical error, which apparently resulted from a simple mistake in an order by a doctor, escaped attention until a clerk picked it up in a routine review of the data.
Brady and Stefano wondered how loads of clinical data and one of the most advanced analytics systems in the country could end up actually concealing reality and preventing information from being used.
In 2020 they founded SPEKTRAL USA LLC with the aim to research, develop, and deploy technologies which reduce the complexity, noise, and latency between reality and its digital representation in a dataset.
Stefano and Brady are serving members of the Harvard University, Harvard Medical School, Harvard Medical School PGME, Harvard Entrepreneurs, MIT, MIT Sloan, and MIT Club of Italy Alumni communities.